Physiologas Technologies Inc.
PrivateLast Round
Series A
Aug 19, 2025
Est. Valuation
$7.7M
Total Funding Raised
$7.9M
Company Overview
Physiologas Technologies Inc. operates in Healthcare & Life Sciences and is based in Japan. Its latest recorded funding round was a Series A round in August 2025.
Physiologas Technologies Inc. is a medical device manufacturing company developing a compact, portable hemodialysis device that does not rely on water infrastructure to make home hemodialysis more accessible.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Physiologas Technologies Inc. Comparables
Compare Physiologas Technologies Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nextkidney | 90% | |
| Kuleana Technology | 88% | |
| Qidni Labs | 85% |
For institutional investors. Book with your work email.
Physiologas Technologies Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Physiologas Technologies Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hokuhoku Capital Co., Ltd. | Series A |
| Chiba Kogin Capital Partners | Series A |
| JMTC Capital | Series A |
| Kyoto University Innovation Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 302% MoM, reaching 936.
- Apr 1, 2026
Monthly visitors grew 135% MoM, reaching 1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 26, 2026
Physiologas Technologies, Inc. competes as one of four finalists at the MedTech Innovator Asia Pacific Showcase & Grand Finals in Singapore.
For institutional investors. Book with your work email.
Physiologas Technologies Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Physiologas Technologies Inc.'s valuation, stock price, and market status.
Is Physiologas Technologies Inc. a public or private company?
Physiologas Technologies Inc. is a private company.
What is the current stock price of Physiologas Technologies Inc.?
Physiologas Technologies Inc. is a private company, so its shares have no public market price. Caplight tracks Physiologas Technologies Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Physiologas Technologies Inc. worth (valuation)?
Physiologas Technologies Inc.'s valuation is estimated at $7.7M based on funding round data.
Can I buy Physiologas Technologies Inc. stock?
Physiologas Technologies Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Physiologas Technologies Inc.'s last funding round?
Physiologas Technologies Inc.'s most recent funding round was Series A on August 19, 2025.
Who are the main investors in Physiologas Technologies Inc.?
Key investors in Physiologas Technologies Inc. include Hokuhoku Capital Co., Ltd., Chiba Kogin Capital Partners, JMTC Capital, Kyoto University Innovation Capital.
Will Physiologas Technologies Inc. IPO soon?
No public IPO plans have been announced for Physiologas Technologies Inc..
How can I track Physiologas Technologies Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Physiologas Technologies Inc.'s shares on secondary markets.